Purchase Order 75N92E20P00083

<p>The National Human Genome Research Institute awarded a purchase order to Fisher Scientific Company L.L.C. for $107,000 on August 7, 2018. The order procures a Cytation 5 imaging multi-mode system and BioSpa automated incubator for placement of performance in Bethesda, Maryland. The purchase order is a firm fixed price acquisition with an ultimate completion date of September 6, 2018.</p>

<p>The National Human Genome Research Institute issued a $30,051.65 delivery order to Illumina, Inc. on May 6, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price, and no set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for an Illumina iScan PC on June 17, 2020, with a firm fixed price of $17,748.00 and an ultimate completion date of July 16, 2020. Place of performance is San Diego, California. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $5,450.23 delivery order to Illumina, Inc. on August 15, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order carries a firm fixed-price structure and an ultimate completion date of September 14, 2018.</p>

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $98,905.32 delivery order to Illumina, Inc. on August 22, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed-price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute (National Institutes of Health) awarded a purchase order to Illumina, Inc. valued at $208,735.16 on June 5, 2026, for firm fixed-price procurement with no set-aside designation. Work is performed in San Diego, California. The order is scheduled for ultimate completion by September 22, 2027.</p>

<p>The National Human Genome Research Institute issued a $24,926.45 delivery order to Illumina, Inc. on September 19, 2019, under a firm fixed-price structure.</p> <p>Place of performance is Bethesda, MD. The order was due for completion on September 2, 2020. No set-aside was applied to this delivery order.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on April 9, 2019, with a ceiling value of $41,948.93 for genetic sequencing equipment and related services.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price with no set-aside applied.</p>